Despite a flurry of executive actions and rhetoric about their supposed impact, thus far most favored nation policies have had little effect on prices that consumers pay.
A doctor discusses common issues and questions around Foundayo, the oral obesity pill approved by the FDA this week.
Medicare by Choice would make available Medicare-like health plans to everyone who wants such coverage. These would then compete against private plans.
Hiring isn’t a neutral process. Why access, networks and visibility shape who gets considered — and what that means for merit.
AI tools are plentiful and being used regularly for health questions. But in the era of potential misinformation, how do we conserve trust?
NASA is returning to the moon with Artemis II. What are the health risks to the astronauts?
Elevance Health’s decision to shakeup its management team is the latest sign it may take more time for the health insurance industry to rebound.
It’s widely known that weight regain is likely after discontinuing medication. But it’s the reversal of cardiovascular risk reduction that researchers found conspicuous.
The Trump administration is investigating admission policies at three medical schools to pressure them to stop building a more diverse healthcare workforce for the U.S.
Repealing the HMO Act is not on any politician’s agenda. But perhaps a better regulated, less heavily profit-oriented system of multiple payers could work in the U.S.